Rituximab added {alpha} IFN + CHVP improves the outcome of follicular lymphoma patients with a high tumor burden:to first analysis of the GELA-GOELAMS FL-2000 randomized trial in 359 patients

查看全文 作　　者：Salles GA;Foussard C ;Nicolas M; 出　　处：《ASH Ann Meeting Abstracts》索引2004年第104卷,共0页